Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial.

Whole pelvis radiation improves cancer-specific and overall survival in muscle-invasive bladder cancer compared to bladder-only radiation. Median cancer-specific survival was 84 months for whole ...

Bladder cancer radiotherapy has evolved significantly over recent years, with adaptive treatment techniques offering a promising approach to overcome the inherent challenges associated with treating a ...

Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced muscle-invasive bladder cancer had lower risk for local recurrence with adjuvant ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

A new study shows that survival rates jumped significantly for patients with locally advanced bladder cancer who were treated with chemotherapy prior to surgery compared with the standard treatment of ...

Bottom line: Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had ...

Cancer incidence in India have been rising steadily. More than 14 lakh new cases are registered every year, and studies ...

After receiving radiation therapy for uterine cancer, you may experience fertility challenges, vaginal dryness, and bowel or bladder problems. Options to manage and relieve your side effects can vary.